🔎 Trials Near Me

Home › Type 2 Diabetes › Virginia

Type 2 Diabetes clinical trials in Virginia

25 studies for Type 2 Diabetes are looking for participants at sites in Virginia.

Cities in Virginia

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • York Clinical Research, LLC, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07595549

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • Chippenham Johnston Willis Medical Center, Richmond
RecruitingHealthy volunteers welcome
Ages 55 and older · All sexes · Updated Sep 28, 2026 · NCT06112418

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Carient Heart & Vascular - Manassas, Manassas
  • Carient Heart and Vascular LLC-Reston, Reston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Manassas
  • Research Site, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Tidewater Physicians Multispecialty Group, Newport News
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07754461

Cooking Health-Oriented Meals to Prevent Dementia and Diabetes

  • Virginia Tech, Blacksburg
RecruitingHealthy volunteers welcome
Ages 50 to 75 · All sexes · Updated Sep 16, 2026 · NCT07661368

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Hampton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Seven Corners Medical Center, Falls Church
  • Carient Heart and Vascular, Manassas
  • York Clinical Research, Norfolk
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • Conquest Research - Arlington, Vienna
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 15, 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Manassas Clinical Research Center, Manassas
  • Centricity Research Suffolk Primary Care, Suffolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07351058

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Leesburg
  • Research Site, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • UVA Health Systems, Charlottesville
RecruitingPhase 3
Ages 10 to 18 · All sexes · Updated Sep 9, 2026 · NCT07282613

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Velocity Clinical Research, Suffolk, Suffolk
  • Conquest Research, Vienna
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
  • Clinical Research Partners, LLC, Richmond
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Manassas Clinical Research Center Inc, Manassas
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Carient Heart and Vascular, Manassas
  • Dominion Medical Associates, Richmond
  • VA Medical Center_Salem, Salem
  • and 1 more
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Arlington
  • Research Site, Newport News
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662109

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Manassas Clinical Research Center, Manassas
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT07527650

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • Riverside Family Medicine Residency Program, Newport News
Recruiting
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07521475

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

  • Burke Internal Medicine and Research, Burke
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 15, 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

  • Burke Internal Medicine & Research, Burke
  • Tekton Research, Midlothian
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07546929

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

  • University of Virginia Center for Diabetes Technology, Charlottesville
Recruiting
Ages 30 to 80 · All sexes · Updated Apr 9, 2026 · NCT05766735

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

  • University of Virginia, Charlottesville
RecruitingHealthy volunteers welcome
Ages 30 to 55 · All sexes · Updated Mar 23, 2026 · NCT04791371

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

  • Foot and Ankle Specialists of the Mid-Atlantic, Salem
Recruiting
Ages 18 and older · All sexes · Updated Feb 10, 2025 · NCT06681428

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.